Skor Kualitas, Nilai, dan Momentum
Kartu ini menunjukkan skor Kualitas, Nilai, dan Momentum untuk perusahaan tersebut.
Laporan Laba Rugi: Pendapatan, Laba Operasional, Laba Bersih
- Nilai operating income untuk Nautilus Biotechnology, Inc. per 2025 Jun 30 adalah -75.02 MM.
- Nilai net income untuk Nautilus Biotechnology, Inc. per 2025 Jun 30 adalah -65.69 MM.
Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
2025-06-30 | -75.02 | -65.69 | |
2025-03-31 | -78.71 | -68.66 | |
2024-12-31 | -81.48 | -70.78 | |
2024-09-30 | -81.50 | -70.21 | |
2024-06-30 | -81.47 | -69.64 | |
2024-03-31 | -79.70 | -67.44 | |
2023-12-31 | -76.15 | -63.67 | |
2023-09-30 | -72.45 | -60.06 | |
2023-06-30 | -69.20 | -58.24 | |
2023-03-31 | -65.66 | -57.13 | |
2022-12-31 | -63.62 | -57.92 | |
2022-09-30 | -64.13 | -61.20 | |
2022-06-30 | -62.88 | -61.65 | |
2022-03-31 | -58.10 | -57.67 | |
2021-12-31 | -50.50 | -50.31 | |
2021-09-30 | -39.00 | -38.98 | |
2021-06-30 | -28.46 | -28.45 | |
2021-03-31 | -21.16 | -21.09 | |
2020-12-31 | -15.74 | -15.62 |
Laporan Laba Rugi: EPS
Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
2025-06-30 | ||
2025-03-31 | -0.55 | -0.55 |
2024-12-31 | -0.56 | |
2024-09-30 | -0.56 | -0.56 |
2024-06-30 | -0.56 | -0.56 |
2024-03-31 | -0.54 | -0.54 |
2023-12-31 | -0.51 | |
2023-09-30 | -0.48 | -0.48 |
2023-06-30 | -0.47 | -0.47 |
2023-03-31 | -0.46 | -0.46 |
2022-12-31 | -0.46 | |
2022-09-30 | -0.49 | -0.49 |
2022-06-30 | -0.49 | -0.49 |
2022-03-31 | -0.54 | -0.54 |
2021-12-31 | -0.60 | |
2021-09-30 | -0.64 | -0.64 |
2021-06-30 | -0.76 | -0.76 |
2021-03-31 | -0.59 | -0.59 |
2020-12-31 | -0.54 |
Arus Kas: Operasi, Investasi, Pendanaan
- Nilai cash from operating activities untuk Nautilus Biotechnology, Inc. per 2025 Jun 30 adalah -54.71 MM.
- Nilai cash from investing activities untuk Nautilus Biotechnology, Inc. per 2025 Jun 30 adalah 63.59 MM.
- Nilai kas dari aktivitas pendanaan untuk Nautilus Biotechnology, Inc. per 2025 Jun 30 adalah 0.69 MM.
Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
2025-06-30 | -54.71 | 63.59 | 0.69 |
2025-03-31 | -56.82 | 63.41 | 0.92 |
2024-12-31 | -59.15 | 66.25 | 1.14 |
2024-09-30 | -58.74 | -11.92 | 0.96 |
2024-06-30 | -57.36 | 8.66 | 0.83 |
2024-03-31 | -55.45 | -7.89 | 0.61 |
2023-12-31 | -51.71 | -43.73 | 0.37 |
2023-09-30 | -48.19 | -66.73 | 0.25 |
2023-06-30 | -46.02 | -91.75 | 0.32 |
2023-03-31 | -45.99 | -54.42 | 0.41 |
2022-12-31 | -45.81 | -25.74 | 0.56 |
2022-09-30 | -45.95 | 44.38 | 0.49 |
2022-06-30 | -50.56 | -27.66 | 0.41 |
2022-03-31 | -45.32 | -147.30 | 329.67 |
2021-12-31 | -39.24 | -138.96 | 327.45 |
2021-09-30 | -33.45 | -116.33 | 327.39 |
2021-06-30 | -22.64 | -48.64 | 327.41 |
2021-03-31 | -17.63 | -9.65 | 73.83 |
2020-12-31 | -14.00 | -25.28 | 75.90 |
Metrik Penilaian: PE, PriceToBook, PriceToTBV
- p/libro untuk Nautilus Biotechnology, Inc. pada 2025 Jun 30 adalah 0.49.
- p/tbv untuk Nautilus Biotechnology, Inc. pada 2025 Jun 30 adalah 0.49.
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
Period End (TTM) | p/e | P/Book | P/TBV |
2025-06-30 | 0.49 | 0.49 | |
2025-03-31 | -1.58 | 0.54 | 0.54 |
2024-12-31 | 0.94 | 0.94 | |
2024-09-30 | -5.24 | 1.55 | 1.55 |
2024-06-30 | -4.23 | 1.14 | 1.14 |
2024-03-31 | 1.31 | 1.31 | |
2023-12-31 | -6.24 | 1.35 | 1.35 |
2023-09-30 | -6.54 | 1.32 | 1.32 |
2023-06-30 | -7.58 | 1.43 | 1.43 |
2023-03-31 | -5.99 | 1.10 | |
2022-12-31 | 0.69 | 0.69 | |
2022-09-30 | -4.29 | 0.78 | 0.78 |
2022-06-30 | -5.79 | 0.96 | 0.96 |
2022-03-31 | -10.71 | 1.48 | 1.48 |
2021-12-31 | -16.50 | 1.70 | 1.70 |
2021-09-30 | -26.74 | 1.95 | 1.95 |
2021-06-30 | |||
2021-03-31 | |||
2020-12-31 |
Metrik Penilaian: EBitToEv, EBit3YrAvgToEv
- EBIT/EV untuk Nautilus Biotechnology, Inc. pada 2025 Jun 30 adalah -1.12.
- EBIT (3 tahun) / EV untuk Nautilus Biotechnology, Inc. pada 2025 Jun 30 adalah -1.07.
Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
2025-06-30 | -1.12 | -1.07 |
2025-03-31 | -0.84 | -0.77 |
2024-12-31 | -0.34 | -0.31 |
2024-09-30 | -0.20 | -0.19 |
2024-06-30 | -0.26 | -0.23 |
2024-03-31 | -0.19 | -0.18 |
2023-12-31 | -0.20 | -0.18 |
2023-09-30 | -0.19 | -0.16 |
2023-06-30 | -0.17 | -0.14 |
2023-03-31 | -0.25 | -0.20 |
2022-12-31 | -1.78 | -0.97 |
2022-09-30 | -1.14 | -0.62 |
2022-06-30 | -0.40 | -0.22 |
2022-03-31 | -0.14 | -0.08 |
2021-12-31 | -0.09 | -0.05 |
2021-09-30 | -0.06 | -0.02 |
2021-06-30 | ||
2021-03-31 | ||
2020-12-31 |
Efektivitas Manajemen
- roa untuk Nautilus Biotechnology, Inc. pada 2025 Jun 30 adalah -0.25.
- roe untuk Nautilus Biotechnology, Inc. pada 2025 Jun 30 adalah -0.29.
- roic untuk Nautilus Biotechnology, Inc. pada 2025 Jun 30 adalah -0.31.
- croic untuk Nautilus Biotechnology, Inc. pada 2025 Jun 30 adalah 0.03.
- ocroic untuk Nautilus Biotechnology, Inc. pada 2025 Jun 30 adalah -0.25.
Period End (TTM) | ROA | ROE | ROIC (Tingkat Pengembalian Investasi Modal) | CROIC | OCROIC |
2025-06-30 | -0.25 | -0.29 | -0.31 | 0.03 | -0.25 |
2025-03-31 | -0.25 | -0.28 | -0.30 | 0.03 | -0.25 |
2024-12-31 | -0.23 | -0.26 | -0.28 | -0.27 | -0.23 |
2024-09-30 | -0.22 | -0.25 | -0.26 | -0.18 | -0.21 |
2024-06-30 | -0.19 | -0.22 | -0.24 | -0.22 | -0.20 |
2024-03-31 | -0.18 | -0.20 | -0.21 | -0.32 | -0.17 |
2023-12-31 | -0.17 | -0.18 | -0.19 | -0.37 | -0.15 |
2023-09-30 | -0.16 | -0.17 | -0.18 | -0.42 | -0.14 |
2023-06-30 | -0.15 | -0.17 | -0.18 | -0.42 | -0.14 |
2023-03-31 | -0.15 | -0.17 | -0.17 | -0.29 | -0.13 |
2022-12-31 | -0.16 | -0.16 | -0.17 | -0.00 | -0.13 |
2022-09-30 | -0.16 | -0.16 | -0.17 | -0.00 | -0.13 |
2022-06-30 | -0.15 | -0.15 | -0.17 | -0.21 | -0.14 |
2022-03-31 | -0.63 | -0.70 | -0.15 | 0.36 | -0.12 |
2021-12-31 | -0.46 | -0.50 | -0.13 | 0.38 | -0.09 |
2021-09-30 | -1.58 | -0.10 | 0.47 | -0.06 | |
2021-06-30 | -1.53 | -1.58 | -0.07 | 0.65 | -0.06 |
2021-03-31 | -1.14 | -1.17 | -0.28 | 0.61 | -0.23 |
2020-12-31 | -0.84 | -0.19 | 0.44 | -0.17 |
Gross Margins
- Margin Kotor
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Margin Keuntungan Bersih
- Margin Bersih (juga dikenal sebagai Margin Keuntungan) adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Bersih. Perhitungannya adalah Pendapatan Bersih / Pendapatan.
- Margin Operasi
- Margin Operasi adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Operasi. Perhitungannya adalah Pendapatan Operasi / Pendapatan.
Period End (TTM) | Margin Kotor | Margin Keuntungan Bersih | Margin Operasi |
2025-06-30 | |||
2025-03-31 | |||
2024-12-31 | |||
2024-09-30 | |||
2024-06-30 | |||
2024-03-31 | |||
2023-12-31 | |||
2023-09-30 | |||
2023-06-30 | |||
2023-03-31 | |||
2022-12-31 | |||
2022-09-30 | |||
2022-06-30 | |||
2022-03-31 | |||
2021-12-31 | |||
2021-09-30 | |||
2021-06-30 | |||
2021-03-31 | |||
2020-12-31 |
Pengenal dan Deskriptor
Kunci Indeks Pusat (CIK) | 1808805 |
Grupong Pang-industriya
SIC 3826 - Laboratory Analytical Instruments |